The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klein, F.
Right arrow Articles by Müschen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klein, F.
Right arrow Articles by Müschen, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*IMATINIB MESYLATE
Medline Plus Health Information
*Stem Cells
The Journal of Immunology, 2005, 174: 367-375.
Copyright © 2005 by The American Association of Immunologists

Tracing the Pre-B to Immature B Cell Transition in Human Leukemia Cells Reveals a Coordinated Sequence of Primary and Secondary IGK Gene Rearrangement, IGK Deletion, and IGL Gene Rearrangement1

Florian Klein*, Niklas Feldhahn*, Jana L. Mooster*, Mieke Sprangers*, Wolf-Karsten Hofmann{ddagger}, Peter Wernet*, Maria Wartenberg{dagger} and Markus Müschen2,*

* Laboratory for Molecular Stem Cell Biology, Center for Biomedical Research and Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany; {dagger} Institute for Neurophysiology, University of Cologne, Cologne, Germany; and {ddagger} Department of Hematology and Oncology, University Hospital, Frankfurt/Main, Germany

The BCR-ABL1 kinase expressed in acute lymphoblastic leukemia (ALL) drives malignant transformation of pre-B cells and prevents further development. We studied whether inhibition of BCR-ABL1 kinase activity using STI571 can relieve this differentiation block. STI571 treatment of leukemia patients induced expression of the Ig L chain-associated transcription factors IRF4 and SPIB, up-regulation of RAG1 and RAG2, C{kappa} and C{lambda} germline transcription, and rearrangement of Ig {kappa} L chain (IGK) and Ig {lambda} L chain (IGL) genes. However, STI571-treated pre-B ALL cells expressed {lambda} L, but almost no {kappa} L chains. This could be explained by STI571-induced rearrangement of the {kappa}-deleting element (KDE), which can delete productively rearranged V{kappa}-J{kappa} joints. Amplifying double-strand breaks at recombination signal sequences within the IGK, KDE, and IGL loci revealed a coordinated sequence of rearrangement events induced by STI571: recombination of IGK gene segments was already initiated within 1 h after STI571 treatment, followed by KDE-mediated deletion of V{kappa}-J{kappa} joints 6 h later and, ultimately, IGL gene rearrangement after 12 h. Consistently, up-regulation of C{kappa} and C{lambda} germline transcripts, indicating opening of IGK and IGL loci, was detected after 1 and 6 h for IGK and IGL, respectively. Continued activity of the recombination machinery induced secondary IGK gene rearrangements, which shifted preferential usage of upstream located J{kappa}- to downstream J{kappa}-gene segments. Thus, inhibition of BCR-ABL1 in pre-B ALL cells 1) recapitulates early B cell development, 2) directly shows that IGK, KDE, and IGL genes are rearranged in sequential order, and 3) provides a model for Ig L chain gene regulation in the human.




This article has been cited by other articles:


Home page
J. Immunol.Home page
W. Su, J. N. Gordon, F. Barone, L. Boursier, W. Turnbull, S. Mendis, D. K. Dunn-Walters, and J. Spencer
Lambda Light Chain Revision in the Human Intestinal IgA Response
J. Immunol., July 15, 2008; 181(2): 1264 - 1271.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Hsu and M. F. Criscitiello
Diverse Immunoglobulin Light Chain Organizations in Fish Retain Potential to Revise B Cell Receptor Specificities
J. Immunol., August 15, 2006; 177(4): 2452 - 2462.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Feldhahn, P. Rio, B. N. B. Soh, S. Liedtke, M. Sprangers, F. Klein, P. Wernet, H. Jumaa, W.-K. Hofmann, H. Hanenberg, et al.
Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells
PNAS, September 13, 2005; 102(37): 13266 - 13271.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.